Cargando…

Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential

Dexamethasone (DEX), a non-particulate glucocorticoid (GC) to inhibit anti-inflammatory response, has been widely used for the treatment of various diseases such as arthritis, cancer, asthma, chronic obstructive pulmonary disease, cerebral edema, and multiple sclerosis. However, prolonged and/or hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yeon Kyung, Kim, Sang-Woo, Park, Jun-Young, Kang, Woong Chol, Kang, Youn Joo, Khang, Dongwoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557625/
https://www.ncbi.nlm.nih.gov/pubmed/28848352
http://dx.doi.org/10.2147/IJN.S142122
_version_ 1783257246550982656
author Lee, Yeon Kyung
Kim, Sang-Woo
Park, Jun-Young
Kang, Woong Chol
Kang, Youn Joo
Khang, Dongwoo
author_facet Lee, Yeon Kyung
Kim, Sang-Woo
Park, Jun-Young
Kang, Woong Chol
Kang, Youn Joo
Khang, Dongwoo
author_sort Lee, Yeon Kyung
collection PubMed
description Dexamethasone (DEX), a non-particulate glucocorticoid (GC) to inhibit anti-inflammatory response, has been widely used for the treatment of various diseases such as arthritis, cancer, asthma, chronic obstructive pulmonary disease, cerebral edema, and multiple sclerosis. However, prolonged and/or high-dose GC therapy can cause various serious adverse effects (adrenal insufficiency, hyperglycemia, Cushing’s syndrome, osteoporosis, Charcot arthropathy, etc). In this study, developed DEX-carbon nanotube (CNT) conjugates improved intracellular drug delivery via increased caveolin-dependent endocytosis and ultimately suppressed the expression of major pro-inflammatory cytokines in tumor necrosis factor-α (TNF-α)-stimulated human fibroblast-like synoviocytes (FLS) at low drug concentrations. Specifically, DEX on polyethylene-glycol (PEG)-coated CNTs induced caveolin uptake, recovered mitochondrial disruption, and inhibited reactive oxygen species production by targeting mitochondria that was released from the early endosome in TNF-α-stimulated FLS. The obtained results clearly demonstrated that DEX-PEG-coated CNTs significantly inhibited the inflammation by FLS in rheumatoid arthritis (RA) by achieving greater drug uptake and efficient intracellular drug release from the endosome, thus suggesting a mechanism of effective low-dose GC therapy to treat inflammatory diseases, including RA and osteoarthritis.
format Online
Article
Text
id pubmed-5557625
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-55576252017-08-28 Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential Lee, Yeon Kyung Kim, Sang-Woo Park, Jun-Young Kang, Woong Chol Kang, Youn Joo Khang, Dongwoo Int J Nanomedicine Original Research Dexamethasone (DEX), a non-particulate glucocorticoid (GC) to inhibit anti-inflammatory response, has been widely used for the treatment of various diseases such as arthritis, cancer, asthma, chronic obstructive pulmonary disease, cerebral edema, and multiple sclerosis. However, prolonged and/or high-dose GC therapy can cause various serious adverse effects (adrenal insufficiency, hyperglycemia, Cushing’s syndrome, osteoporosis, Charcot arthropathy, etc). In this study, developed DEX-carbon nanotube (CNT) conjugates improved intracellular drug delivery via increased caveolin-dependent endocytosis and ultimately suppressed the expression of major pro-inflammatory cytokines in tumor necrosis factor-α (TNF-α)-stimulated human fibroblast-like synoviocytes (FLS) at low drug concentrations. Specifically, DEX on polyethylene-glycol (PEG)-coated CNTs induced caveolin uptake, recovered mitochondrial disruption, and inhibited reactive oxygen species production by targeting mitochondria that was released from the early endosome in TNF-α-stimulated FLS. The obtained results clearly demonstrated that DEX-PEG-coated CNTs significantly inhibited the inflammation by FLS in rheumatoid arthritis (RA) by achieving greater drug uptake and efficient intracellular drug release from the endosome, thus suggesting a mechanism of effective low-dose GC therapy to treat inflammatory diseases, including RA and osteoarthritis. Dove Medical Press 2017-08-10 /pmc/articles/PMC5557625/ /pubmed/28848352 http://dx.doi.org/10.2147/IJN.S142122 Text en © 2017 Lee et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Lee, Yeon Kyung
Kim, Sang-Woo
Park, Jun-Young
Kang, Woong Chol
Kang, Youn Joo
Khang, Dongwoo
Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title_full Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title_fullStr Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title_full_unstemmed Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title_short Suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
title_sort suppression of human arthritis synovial fibroblasts inflammation using dexamethasone-carbon nanotubes via increasing caveolin-dependent endocytosis and recovering mitochondrial membrane potential
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5557625/
https://www.ncbi.nlm.nih.gov/pubmed/28848352
http://dx.doi.org/10.2147/IJN.S142122
work_keys_str_mv AT leeyeonkyung suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential
AT kimsangwoo suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential
AT parkjunyoung suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential
AT kangwoongchol suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential
AT kangyounjoo suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential
AT khangdongwoo suppressionofhumanarthritissynovialfibroblastsinflammationusingdexamethasonecarbonnanotubesviaincreasingcaveolindependentendocytosisandrecoveringmitochondrialmembranepotential